OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - PROTEOSTASIS THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 22 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2018$262,000,000
-61.9%
80,903
-31.4%
0.01%
-25.0%
Q4 2017$688,000,000
+450.4%
118,000
+806.6%
0.01%
+500.0%
Q1 2016$125,000,000–13,016–0.00%–
 Download
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q1 2016.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders